trending Market Intelligence /marketintelligence/en/news-insights/trending/h-kwzmcrsmh4oleycz1lsa2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Aurinia closes $28.8M bought-deal offering

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


Aurinia closes $28.8M bought-deal offering

Aurinia Pharmaceuticals Inc. closed its $28.8 million bought-deal offering, which included $3.8 million pursuant to an exercise of the underwriter's overallotment option, for the sale of 12,777,775 units at $2.25 per unit.

Each unit consists of one common share and one-half of one common share purchase warrant. Each warrant will be exercisable into one share for $3 apiece for a period of 5 years after the offering closes.

H.C. Wainwright & Co. LLC was sole book-running manager and Cormark Securities Inc. was co-manager for the offering.